{"id":52163,"date":"2020-04-09T09:33:10","date_gmt":"2020-04-09T13:33:10","guid":{"rendered":"https:\/\/asweetlife.org\/?p=52163"},"modified":"2020-04-09T09:43:07","modified_gmt":"2020-04-09T13:43:07","slug":"eversense-implantable-glucose-monitor-halts-sales-amid-covid-outbreak","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=52163","title":{"rendered":"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak"},"content":{"rendered":"<p>Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and marketing efforts.<\/p>\n<p>The Eversense appears to be another unfortunate casualty of the COVD-19 pandemic. Eversense sensors are inserted under the skin by a trained doctor, and with most non-essential clinic visits canceled in the US and elsewhere, it must be difficult to imagine any new customers adopting the system in the near term. The financial devastation wrought by the pandemic couldn\u2019t help either; the new system was not yet covered universally by insurance providers.<\/p>\n<p>Stressing that existing customers will continue to receive support, Senseonics \u201cregretfully\u201d announced that they had laid off the majority of their US sales and clinical organization workforce. The change is explained in an open letter written by Tim Goodnow, President &amp; CEO, published on the <a href=\"https:\/\/www.eversensediabetes.com\/\">Eversense website landing page<\/a>:<\/p>\n<p><em>To ensure continuity of care for our existing customers, we are reducing commercialization expenditures to focus our resources solely on existing customers. This will mean stopping sales and marketing efforts to acquire\u00a0<strong>new<\/strong>\u00a0Eversense users in the US. No\u00a0<strong>new<\/strong>\u00a0patients or clinics will be initiated. Only people currently using Eversense and those whose sensor has shipped will be inserted, as insurance allows.\u00a0<\/em><\/p>\n<p>The Eversense system had generated considerable excitement in the diabetes community, including some early rave reviews for accuracy and convenience. The appeal of an implantable CGM system is easy to understand. The Eversense system eliminates the frequent self-administered sensor insertions required by other CGMs, and the transmitter can be removed, recharged and replaced without fuss.<\/p>\n<p>The 90-day system <a href=\"https:\/\/asweetlife.org\/fda-approves-eversense-first-implantable-cgm\/\">won FDA approval<\/a> in 2018, and the company is currently engaged in clinical trials to prove the safety and efficacy of a 180-day version. Now we can only guess as to the future of the new system. Goodnow\u2019s letter asserts that \u201cthe company remains committed to the development and submission to the FDA of the US Eversense\u00ae XL product (up to 180 days),\u201d and that this next generation product will receive a renewed focus. Nevertheless, it may be difficult to be optimistic about the business\u2019 future, given such a dramatic downturn in their immediate fortunes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&hellip;<\/p>\n","protected":false},"author":131,"featured_media":49219,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1437],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak<\/title>\n<meta name=\"description\" content=\"Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and marketing efforts.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=52163\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=52163\",\"url\":\"https:\/\/asweetlife.org\/?p=52163\",\"name\":\"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=52163#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=52163#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg\",\"datePublished\":\"2020-04-09T13:33:10+00:00\",\"dateModified\":\"2020-04-09T13:43:07+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and marketing efforts.\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=52163#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=52163\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=52163#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg\",\"width\":2560,\"height\":1863,\"caption\":\"Eversense CGM Watch and iPhone\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=52163#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak","description":"Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and marketing efforts.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=52163","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=52163","url":"https:\/\/asweetlife.org\/?p=52163","name":"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=52163#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=52163#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg","datePublished":"2020-04-09T13:33:10+00:00","dateModified":"2020-04-09T13:43:07+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Senseonics, the maker of the Eversense 90-day implantable continuous glucose monitor (CGM), has halted all new sales and marketing efforts.","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=52163#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=52163"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=52163#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2018\/06\/Eversense-CGM-Watch-and-iPhone-scaled.jpg","width":2560,"height":1863,"caption":"Eversense CGM Watch and iPhone"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=52163#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Eversense Implantable Glucose Monitor Halts Sales Amid COVID Outbreak"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/52163"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=52163"}],"version-history":[{"count":2,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/52163\/revisions"}],"predecessor-version":[{"id":52167,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/52163\/revisions\/52167"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/49219"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=52163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=52163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=52163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}